DCAT SHARP SOURCING 2017
For Sharp Sourcing 2017, the Buyers’ Forum will explore three
topics: (1) talent in sourcing and procurement with a focus
on Millennials and Generation Y professionals; (2) collaborative supply-chain planning; and ( 3) technology-led sourcing.
The Buyers’ Forum consists of short presentations, followed
by table discussions of key points of interest, and concluding
with a read-out from those discussions for knowledge sharing
Talent in sourcing and procurement. A 2016 Gallup report,“How
Millennials Want to Work and Live,” showed that 59% of Millennials say opportunities to learn and grow in their jobs are extremely important compared to only 41% of baby boomers. The
study showed that Millennials assign the most importance to this
job attribute, representing the greatest difference between what
this generation values in a job and what other generations value.
But how does that attribute translate practically, and what
unique skills or insights can early-career professionals bring to
the table? Much attention has been focused on this age group,
but the voice of understanding is typically from those outside
this age group, so what do these early-career professionals have
to say? To gain a first-hand perspective, two early-career professionals, respectively from Bristol-Myers Squibb and Merck & Co.
Inc., will share insights on the unique skills of this age group,
what senior professionals can learn, and how their companies are
shaping their skills to meet current and future talent demands in
sourcing and procurement.
Collaborative supply-chain planning. Strategic supplier relationships are crucial in bringing value to a company, but how can
those relationships be best managed in light of supplier consolidation? When a company expands its offerings from a merger or
acquisition, how can that be leveraged and managed for mutual
benefit? Janssen Pharmaceuticals, part of Johnson & Johnson,
will provide insight from its experience that resulted in a new
collaborative supply-chain planning program with a key supplier.
Technology-led sourcing. Product complexity in the pharmaceutical industry is increasing, whether it is in the molecule itself as
an API, the formulation to enable delivery of a new drug, or in the
manufacture of the API or drug product. As product complexity
increases, so do the technology requirements to make that product. Merck & Co., Inc. will provide insights on sourcing specialized technology services from CDMOs and CMOs.
Small to mid-sized pharmaceutical companies are an important
customer base for suppliers, CMDOs, and CMOs. So what is the
outlook for this customer base, and what are key topical issues
impacting the customer/supplier relationship? The Suppliers’Fo-rum at DCAT Sharp Sourcing will examine those questions.
A Wall Street outlook. RBC Capital Markets LLC will provide a
Wall Street view on financing and partnering activity of small-to-mid-sized pharma companies and the financial outlook for suppliers, CMOs, and CDMOs.
Starting materials. Defining starting materials, the beginning
point for a cGMP manufacturing process, is crucial in the develop-
ment and manufacture of an API, particularly in an outsourced proj-
ect, in defining project scope, cost, and related requirements. Guide-
lines by the International Conference on Harmonization (ICH), ICH
Q7 and ICH Q11, and further guidance by regulatory authorities,
such as the US Food and Drug Administration and the European
Medicines Agency, provide direction, but the definition of starting
materials is specific to a given process and can be the subject of dis-
cussion with regulators. Corbus Pharmaceuticals will provide per-
spective, including risk-reward considerations, in how this issue may
be addressed when working with CDMOs and CMOs.
Outsourcing strategies. In outsourcing the development and/or
manufacture of an API and/or drug product, what are some best
practices and lessons learned from a pharma company perspective
that can benefit both parties in the pharma customer/supplier relationship? The Suppliers’ Forum will provide insights from Eli Lilly
and Company, which will discuss its experience in small-molecule
early-stage development, and Paratek Pharmaceuticals, which will
provide a perspective from a smaller biopharmaceutical company in
its supplier relationships for both APIs and drug products.
DCAT JOINT AFTERNOON SESSION
Buyers and suppliers come together for the Joint Afternoon Session to learn from leading executives on practical ways to resolve
common challenges in sourcing and procurement and on new
tools for managing the customer/supplier relationship. This session
will feature a roundtable of chief procurement officers (CPOs), a
discussion of supply-chain financing, a new approach in satisfying
working capital requirements, and a market outlook for APIs.
CPO roundtable. In this session, CPOs from Johnson & Johnson, Pfizer, Biogen, and GE Healthcare discuss specific challenges
facing procurement organizations and their company initiatives,
including how they are involving suppliers, to resolve those challenges. Topics that will be discussed include: optimizing operating models through global shared services; using Big Data analytics in procurement; brand creation for the global procurement
function; and supplier-enabled innovation.
Supply-chain financing. As pharmaceutical companies seek to
improve their working-capital position, they commonly ask for
extended payment terms from their suppliers, a situation that
is not advantageous for suppliers. Supply-chain financing, an
emerging approach first adopted outside the pharmaceutical
industry, may be a solution to resolve that working-capital dilemma. Siemens, recently cited in the Harvard Business Review as
one leading multinational company applying this approach, will
provide an overview on supply-chain financing, and Pfizer will
provide perspective on how it is applying it with suppliers.
API market outlook. Clarivate Analytics will provide a global
market overview of the demand and supply outlook for APIs, for
both innovator and generic drugs (small molecules and biologics)
globally and in key developed and emerging markets.
NETWORKING AND KEYNOTE SPEAKER
DCAT Sharp Sourcing will also feature as its keynote speaker,
Phil Simms, Super Bowl XXI Most Valuable Player, former quarterback of the New York Giants, and NFL television analyst. Following his presentation on“Leading a Team,” a networking reception follows.
Information about DCAT Sharp Sourcing, including how to
register, may be found at https://dcat.org/SharpSourcing.htm. CP